Collplant Biotechnologies Ltd
SEC CIK 1631487 · CLGN · last insider filing 2026-04-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Evans Hugh M | Director | filed 2026 - 2026 |
| Tal Yehiel | Director · Chief Executive Officer | filed 2026 - 2026 |
| Penn Elan | Director | filed 2026 - 2026 |
| Lask Alisa | Director | filed 2026 - 2026 |
| Havron Avraham | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Rotem Eran | Deputy CEO and CFO | filed 2026 - 2026 |
| Bensimon Philippe | VP Regulations and QA | filed 2026 - 2026 |
| Fahimipoor Oren | VP Operations | filed 2026 - 2026 |
| Bagley Bowman | VP Commercial North America | filed 2026 - 2026 |
| Abelis Bar Berta | VP Legal | filed 2026 - 2026 |
| Seror Jasmine | VP Product Development | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.